Trials / Completed
CompletedNCT05813886
Evaluation of Dynamic Balance After Recovery From COVID 19 Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (actual)
- Sponsor
- October 6 University · Academic / Other
- Sex
- All
- Age
- 30 Years – 40 Years
- Healthy volunteers
- —
Summary
effect of post covid-19 on dynamic balance in patients after recovery from covid-19 disease.
Detailed description
effect of post covid-19 on dynamic balance in patients after recovery from COVID disease. patients will treated with medical protocol of COVID 19 an out-patient clinic , and followed up by the chest specialist . The balance tests of the patients were performed 2 to 14 weeks after their recovery from the disease, which was confirmed by the evaluations of the COVID staff and negative polymerase chain reaction test.the patients will evaluated using questionnaires. First, the question will whether feeling in balance in the daily life or not. The answer will classified as "yes"or "no". Second, asked to fill "Dizziness Handicap Inventory"(DHI), which is a multidimensional self- assessment scale created to evaluate the effects of dizziness and balance problems on the quality of life as well as the level of disability of the patients. Assess balance , which consists of a movable balance platform that provides up to 20 of surface tilt in a 360 range of motion. The platform is interfaced with computer software that enables the device to serve as an objective assessment of balance . The measure of postural stability includes the overall (OA), the anteroposterior (AP) and the mediolateral (ML) stability scores. A high score in the OA index indicates poor balance. The OA stability score is believed to be the best indicator of the overall ability of the patient to balance the platform
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | biodex balance system | The balance tests of the patients were performed 2 to24 WEEKS after their recovery from the disease, which was confirmed by the evaluations of the Covid-19 staff and negative polymerase chain reaction test. |
Timeline
- Start date
- 2022-02-20
- Primary completion
- 2022-12-30
- Completion
- 2023-03-21
- First posted
- 2023-04-14
- Last updated
- 2023-04-19
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05813886. Inclusion in this directory is not an endorsement.